Clinical Trials and Research News Weekly Roundup | FDA Greenlight for Ivermectin Clinical Trial

TrialSite News Ivermectin


Southern California Research Institute Receives FDA Greenlight for Ivermectin Clinical Trial: California’s ProgenaBiome recently received the greenlight from the U.S. Food and Drug Administration (FDA) for two Phase 2 clinical trials involving investigational therapies targeting COVID-19: one of them based on hydroxychloroquine and the other ivermectin. With approved investigational new drug (IND) applications, a dynamic and accomplished California gastroenterologist andy principal investigator, Dr. Sabine Hazan, and team now prepare to conduct important studies investigating two possible economical therapies for treating SARS-CoV-2, the virus behind the COVID-19 pandemic.
Experts Debate While West Texas Doctor Stands Ground on Inhaled Steroid for COVID-19: On July 14, we published “West Texas Doctor Bartlett: Is He on to a ‘Silver Bullet’ with Use of Off-Label Inhaled Steroid as COVID-19 Treatment?” This doctor is using budesonide, an inhaled steroid asthma medicine as a key treatment for COVID-19. On August 19, the Texas Standard offered an update. They note that Dr. Bartlett has been using bu...

Note:  If you need assistance with your subscription or would like to discuss a corporate subscription for more than 10 employees please contact us or use the chat (bottom right).

$5 / Month
Individuals at home that are reading our content for personal health care or other non-professional reasons.
Like a Starbucks a month
Personal - Single Payment
$50 for 1 Year
Individuals - reading for personal reasons who prefer to pay for one year in advance with no recurring billing.
18% discount to monthly
$12 / Month
Professionals from the healthcare industry who are subscribing on behalf of their company for work reasons.
Way better than coffee